Ferrandina Gabriella, Distefano Mariagrazia, Mascilini Floriana, Gallotta Valerio, Chiantera Vito, Cosentino Francesco, Costantini Barbara, Ercoli Alfredo, Pedone Anchora Luigi, Fanfani Francesco, Margariti Alessandro Pasquale, Valentini Vincenzo, Scambia Giovanni
Gynecologic Oncology Unit, Fondazione "Policlinico Universitario A. Gemelli", Italy; Institute of Obstetrics/Gynecology, Catholic University, Rome, Rome, Italy.
Gynecologic Oncology Unit, Fondazione "Policlinico Universitario A. Gemelli", Italy.
Eur J Surg Oncol. 2017 Dec;43(12):2270-2276. doi: 10.1016/j.ejso.2017.09.013. Epub 2017 Sep 23.
To identify a subset of cervical cancer (CC) patients administered chemoradiation (CT/RT) plus radical surgery (RS), who can be spared lymphadenectomy, and complications.
430 Stage IB2-IIB patients without LN involvement at imaging were accrued (March 1996-December 2015) at Gynecologic Oncology Unit of the Catholic University of Rome/Campobasso. CT/RT consisted of pelvic irradiation plus cisplatin based chemotherapy. Objective response was evaluated according to RECIST criteria; radical hysterectomy and pelvic ± aortic lymphadenectomy was attempted in patients achieving response or stable disease. Surgical morbidity was classified according to the Chassagne grading system.
421 cases underwent RS; metastatic pelvic and aortic LNs were documented in 10.7%, and 8.8% of cases, respectively. In patients without residual tumor in the cervix, there was only 1 case (0.53%) with positive pelvic LNs, and 1 case (2.3%) with metastatic aortic LNs. Analysis of patients according to pre- and post-CT/RT imaging was able to select cases without any metastatic LNs: in patients with negative pelvic LNs at pre- and post-CT/RT imaging, none of cases without residual disease in the cervix had metastatic pelvic or aortic LNs. Of 149 early complications, 76 (51.0%) were lymphovascular. The most frequent late complications were lymphovascular (N = 25/61, 41.0%).
Lymphadenectomy could be avoided in stage IB2-IIB CC patients undergoing preoperative CT/RT, when a careful evaluation of pre- and post-CT/RT imaging and histological assessment of no residual disease in the cervix is made. This approach may avoid lymphadenectomy in 40% of patients with a favourable impact on lymphovascular morbidity.
确定接受放化疗(CT/RT)加根治性手术(RS)的宫颈癌(CC)患者亚组,这些患者可避免淋巴结清扫及相关并发症。
1996年3月至2015年12月,罗马天主教大学/坎波巴索妇科肿瘤病房纳入430例影像学检查无淋巴结转移的IB2-IIB期患者。CT/RT包括盆腔放疗加顺铂化疗。根据RECIST标准评估客观缓解情况;对达到缓解或疾病稳定的患者尝试进行根治性子宫切除术及盆腔±主动脉旁淋巴结清扫。手术并发症根据Chassagne分级系统分类。
421例患者接受了RS;盆腔和主动脉旁淋巴结转移分别在10.7%和8.8%的病例中被记录。宫颈无残留肿瘤的患者中,盆腔淋巴结阳性仅1例(0.53%),主动脉旁淋巴结转移1例(2.3%)。根据CT/RT前后影像学分析能够筛选出无任何转移淋巴结的病例:CT/RT前后盆腔淋巴结阴性且宫颈无残留疾病的患者中,无一例有盆腔或主动脉旁淋巴结转移。149例早期并发症中,76例(51.0%)为淋巴管相关并发症。最常见的晚期并发症是淋巴管相关并发症(N = 25/61,41.0%)。
对于接受术前CT/RT的IB2-IIB期CC患者,若仔细评估CT/RT前后影像学且宫颈无残留疾病的组织学评估结果良好,则可避免淋巴结清扫。该方法可使40%的患者避免淋巴结清扫,并对淋巴管相关发病率产生有利影响。